An Update on Botulinum Toxin in Neurology

Shannon Y Chiu; Matthew R Burns; Irene A Malaty

doi:10.1016/j.ncl.2020.09.014

An Update on Botulinum Toxin in Neurology

Neurol Clin. 2021 Feb;39(1):209-229. doi: 10.1016/j.ncl.2020.09.014. Epub 2020 Nov 7.

Authors

Shannon Y Chiu¹, Matthew R Burns¹, Irene A Malaty²

Affiliations

¹ Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, 3009 SW Williston Road, Gainesville, FL 32608, USA.
² Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, 3009 SW Williston Road, Gainesville, FL 32608, USA. Electronic address: Irene.malaty@neurology.ufl.edu.

PMID: 33223084
DOI: 10.1016/j.ncl.2020.09.014

Abstract

Botulinum neurotoxin (BoNT) is an effective treatment for many neurologic disorders. This article gives a comprehensive overview of the clinical applications of BoNT across the field of neurology.

Keywords: Blepharospasm; Botox; Botulinum toxin; Dystonia; Emerging; Hemifacial spasm; Migraine; Spasticity.

Publication types

Review

MeSH terms

Botulinum Toxins, Type A / therapeutic use*
Humans
Nervous System Diseases / drug therapy*
Neurology / methods
Neuromuscular Agents / therapeutic use*
Treatment Outcome

Substances

Neuromuscular Agents
Botulinum Toxins, Type A